Clinical Trials Browser

Phase 2 × FED × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all

NCT00086203 2015-03-25

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell